Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; no other visible changes to content or layout.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a new Revision: v3.4.2 and the previous notices about government funding and operating status have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedThe page now displays a government funding/open status notice and shows the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedAdd glossary toggle and update metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), while removing older labels (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).SummaryDifference0.2%

- Check103 days agoChange DetectedAdded location sections for 17 sites across Alabama, Connecticut, District of Columbia, Florida, Georgia, Louisiana, Maryland, Michigan, Missouri, New Jersey, New York, Pennsylvania, South Carolina, Tennessee, Texas, Washington, and Wisconsin. Also updated the page revision to v3.3.3.SummaryDifference2%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.